LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Endoplasmic reticulum stress causes EBV lytic replication.

    Taylor, Gwen Marie / Raghuwanshi, Sandeep K / Rowe, David T / Wadowsky, Robert M / Rosendorff, Adam

    Blood

    2011  Volume 118, Issue 20, Page(s) 5528–5539

    Abstract: Endoplasmic reticulum (ER) stress triggers a homeostatic cellular response in mammalian cells to ensure efficient folding, sorting, and processing of client proteins. In lytic-permissive lymphoblastoid cell lines (LCLs), pulse exposure to the chemical ER- ...

    Abstract Endoplasmic reticulum (ER) stress triggers a homeostatic cellular response in mammalian cells to ensure efficient folding, sorting, and processing of client proteins. In lytic-permissive lymphoblastoid cell lines (LCLs), pulse exposure to the chemical ER-stress inducer thapsigargin (TG) followed by recovery resulted in the activation of the EBV immediate-early (BRLF1, BZLF1), early (BMRF1), and late (gp350) genes, gp350 surface expression, and virus release. The protein phosphatase 1 a (PP1a)-specific phosphatase inhibitor Salubrinal (SAL) synergized with TG to induce EBV lytic genes; however, TG treatment alone was sufficient to activate EBV lytic replication. SAL showed ER-stress-dependent and -independent antiviral effects, preventing virus release in human LCLs and abrogating gp350 expression in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated B95-8 cells. TG resulted in sustained BCL6 but not BLIMP1 or CD138 expression, which is consistent with maintenance of a germinal center B-cell, rather than plasma-cell, phenotype. Microarray analysis identified candidate genes governing lytic replication in LCLs undergoing ER stress.
    MeSH term(s) Carcinogens/pharmacology ; Cell Line ; Cinnamates/pharmacology ; Endoplasmic Reticulum Stress/physiology ; Enzyme Inhibitors/pharmacology ; Epstein-Barr Virus Infections/metabolism ; Epstein-Barr Virus Infections/physiopathology ; Epstein-Barr Virus Infections/virology ; Eukaryotic Initiation Factor-2/metabolism ; Gene Expression Profiling ; Gene Expression Regulation, Viral/physiology ; Genes, Immediate-Early/genetics ; Germinal Center/cytology ; Germinal Center/metabolism ; Germinal Center/virology ; Herpesvirus 4, Human/drug effects ; Herpesvirus 4, Human/genetics ; Herpesvirus 4, Human/growth & development ; Humans ; Immediate-Early Proteins/genetics ; Lymphocytes/cytology ; Lymphocytes/metabolism ; Lymphocytes/virology ; Lymphoma/metabolism ; Lymphoma/virology ; Membrane Glycoproteins/genetics ; Plasma Cells/cytology ; Plasma Cells/metabolism ; Plasma Cells/virology ; Tetradecanoylphorbol Acetate/pharmacology ; Thapsigargin/pharmacology ; Thiourea/analogs & derivatives ; Thiourea/pharmacology ; Trans-Activators/genetics ; Viral Matrix Proteins/genetics ; Virus Replication/drug effects ; Virus Replication/physiology
    Chemical Substances BRLF1 protein, Human herpesvirus 4 ; BZLF1 protein, Herpesvirus 4, Human ; Carcinogens ; Cinnamates ; Enzyme Inhibitors ; Eukaryotic Initiation Factor-2 ; GP 300-350, Epstein-Barr virus ; Immediate-Early Proteins ; Membrane Glycoproteins ; Trans-Activators ; Viral Matrix Proteins ; salubrinal ; Thapsigargin (67526-95-8) ; Thiourea (GYV9AM2QAG) ; Tetradecanoylphorbol Acetate (NI40JAQ945)
    Language English
    Publishing date 2011-08-17
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2011-04-347112
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases.

    Wilkie, Gwen M / Taylor, Clare / Jones, Marie M / Burns, David M / Turner, Marc / Kilpatrick, David / Amlot, Peter L / Crawford, Dorothy H / Haque, Tanzina

    Journal of immunotherapy (Hagerstown, Md. : 1997)

    2004  Volume 27, Issue 4, Page(s) 309–316

    Abstract: Adoptive immunotherapy using Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL) generated ex vivo can be an effective treatment of EBV-positive posttransplantation lymphoproliferative disease (PTLD). We describe the establishment of a ... ...

    Abstract Adoptive immunotherapy using Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL) generated ex vivo can be an effective treatment of EBV-positive posttransplantation lymphoproliferative disease (PTLD). We describe the establishment of a cryopreserved repository of allogeneic virus-specific CTL lines, to our knowledge the first of its kind in the world. CTL lines were grown by weekly stimulation with autologous EBV immortalized lymphoblastoid cell lines (LCLs) from 96 EBV-seropositive blood donors. Analysis of 60 CTL lines grown continuously for 7 to 10 weeks showed an average proportional weekly increase in cell numbers of 1.4, with an overall increase ranging from 1.1 to 83.4. The greatest increase occurred during the early culture period. After four rounds of stimulation, killing of autologous LCLs was generally high (mean 48%); however, most lines required 9 or 10 stimulations to reduce the killing of nonspecific targets. Overall, 79% of CTLs generated showed acceptable levels of specific killing. Phenotypically, the CTL lines consisted of TCRalpha beta+, CD8+ T cells (medians 97% and 90% respectively) with a minority population of CD4+ T cells (median 2%). Most cells expressed the activation and differentiation markers, HLA-DR, CD26, CD45RO, CD69, and CD150. Favorable results have been obtained in an open trial using partially HLA-matched, allogeneic CTLs from this bank to treat PTLD patients. This now represents a single resource that can provide therapeutic CTLs rapidly on a countrywide basis, superseding the time-consuming, expensive practice of generating autologous CTLs from each patient requiring treatment. Additionally, other patient groups, such as those with EBV-positive Hodgkin disease, may benefit from CTL treatment.
    MeSH term(s) Blood Banking/methods ; Blood Donors ; Cells, Cultured ; Epstein-Barr Virus Infections/immunology ; Epstein-Barr Virus Infections/therapy ; Epstein-Barr Virus Infections/virology ; Herpesvirus 4, Human/physiology ; Humans ; Immunotherapy/methods ; Phenotype ; T-Lymphocytes, Cytotoxic/cytology ; T-Lymphocytes, Cytotoxic/immunology ; T-Lymphocytes, Cytotoxic/radiation effects
    Language English
    Publishing date 2004-01-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1064067-8
    ISSN 1537-4513 ; 1524-9557 ; 1053-8550
    ISSN (online) 1537-4513
    ISSN 1524-9557 ; 1053-8550
    DOI 10.1097/00002371-200407000-00007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top